Su An Selected Research

Dacarbazine (DIC)

1/2022

Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Su An Research Topics

Disease

10	Neoplasms (Cancer) 01/2023 - 01/2015
6	Lung Neoplasms (Lung Cancer) 01/2023 - 03/2016
5	Carcinogenesis 01/2023 - 01/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024
1	Gouty Arthritis 11/2023
1	Gout 11/2023
1	Fibrosarcoma 01/2023
1	Angina Pectoris 10/2022
1	Coronary Disease (Coronary Heart Disease) 10/2022
1	Myocardial Infarction 04/2021
1	No-Reflow Phenomenon 04/2021
1	ST Elevation Myocardial Infarction 04/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Pain (Aches) 01/2018
1	Cardiac Arrhythmias (Arrythmia) 11/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2016
1	Hypersensitivity (Allergy) 07/2013

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2015
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2023 - 01/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2015
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2016
2	raf KinasesIBA 01/2015 - 01/2015
2	Phosphotransferases (Kinase)IBA 01/2015 - 01/2015
1	ML-162IBA 04/2024
1	Thioredoxin Reductase 1IBA 04/2024
1	Cisplatin (Platino)FDA LinkGeneric 04/2024
1	jolkinolide BIBA 04/2024
1	DiterpenesIBA 04/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024
1	LipidsIBA 04/2024
1	Acetic Acid (Vinegar)FDA LinkGeneric 11/2023
1	Uric Acid (Urate)IBA 11/2023
1	potassium oxonateIBA 11/2023
1	Gout Suppressants (Antigout Agents)IBA 11/2023
1	BenzbromaroneIBA 11/2023
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023
1	Xue-Fu-Zhu-Yu decoctionIBA 10/2022
1	osimertinibIBA 01/2022
1	dictamnineIBA 01/2022
1	Gefitinib (Iressa)FDA Link 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Nicorandil (SG 75)IBA 04/2021
1	Proto-Oncogene Proteins c-metIBA 01/2021
1	Serotonin ReceptorsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	5-HT1B Serotonin ReceptorIBA 01/2021
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2020
1	Messenger RNA (mRNA)IBA 11/2020
1	Fluorouracil (Carac)FDA LinkGeneric 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018
1	barium chloride (barium dichloride)IBA 11/2016
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2016
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2016
1	LigandsIBA 01/2016
1	Lysophosphatidic Acid ReceptorsIBA 01/2016
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2016
1	AllergensIBA 07/2013

Therapy/Procedure

7	Therapeutics 04/2024 - 07/2013
1	Intraperitoneal Injections 11/2023
1	Injections 11/2023
1	Patient Readmission 04/2021
1	Percutaneous Coronary Intervention 04/2021
1	Intravenous Injections 11/2016
1	Thoracotomy 03/2016